Zenas BioPharma, Inc. Common Stock (ZBIO) — Cash Flow Quality Index
Latest as of September 2023:
0.89x
Zenas BioPharma, Inc. Common Stock (ZBIO) has a Cash Flow Quality Index of 0.89x as of September 2023. Operating cash flow of $31.85 Million is below net income of $35.61 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Zenas BioPharma, Inc. Common Stock (ZBIO) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
0.89x
Operating CF / Net Income
Operating Cash Flow
$31.85 Million
USD
Net Income
$35.61 Million
USD
Data as of
Sep 2023
Most recent filing
Annual Cash Flow Quality Index for Zenas BioPharma, Inc. Common Stock (None–None)
Year-by-year earnings quality comparison for Zenas BioPharma, Inc. Common Stock. For live market cap and the full company financial profile, see Zenas BioPharma, Inc. Common Stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.